BRAND LOYALTY, ENTRY, AND PRICE-COMPETITION IN PHARMACEUTICALS AFTER THE 1984 DRUG-ACT

被引：279

作者：

GRABOWSKI, HG

VERNON, JM

机构：

来源：

关键词：

D O I：

10.1086/467257

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：331 / 350

页数：20

共 14 条

[1] CAVES RE, 1991, BROOKINGS PAP ECO AC, P1
[2] CONRAD CA, 1983, INT J IND ORGAN, V1, P353
[3] FRANK RG, 1991, 3803 NAT BUR EC RES
[4] DYNAMIC LIMIT PRICING - OPTIMAL PRICING UNDER THREAT OF ENTRY
GASKINS, DW
[J]. JOURNAL OF ECONOMIC THEORY, 1971, 3 (03) : 306 - 322
[5] GRABOWSKI H, 1986, AM ECON REV, V76, P195
[6] A NEW LOOK AT THE RETURNS AND RISKS TO PHARMACEUTICAL RESEARCH-AND-DEVELOPMENT
GRABOWSKI, H
VERNON, J
[J]. MANAGEMENT SCIENCE, 1990, 36 (07) : 804 - 821
[7] GRABOWSKI HG, 1979, LAW CONTEMP PROBL, V43, P43
[8] PERSUASION OR INFORMATION - PROMOTION AND THE SHARES OF BRAND NAME AND GENERIC PHARMACEUTICALS
HURWITZ, MA
CAVES, RE
[J]. JOURNAL OF LAW & ECONOMICS, 1988, 31 (02) : 299 - 320
[9] Masson A., 1985, GENERIC SUBSTITUTION
[10] Scherer F. M., 1990, IND MARKET STRUCTURE